Related Experiment Video
Updated: May 8, 2026

Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
Antiplatelet properties of natural products
1Centro de Investigación Cardiovascular, CSIC-ICCC, Hospital de la Santa Creu i Sant Pau and IIB-Santpau, Spain.
Insights
Natural foods and their compounds, like those in the Mediterranean diet, show promise in preventing cardiovascular diseases by reducing blood clot formation. These dietary components offer cardioprotective effects and antiplatelet activities.
Area of Science:
- Cardiovascular Medicine and Nutrition Science
- Focuses on the intersection of diet, atherothrombosis, and cardiovascular health.
Background:
- Cardiovascular diseases (CVD), driven by atherothrombosis, are leading causes of global mortality.
- Existing treatments include managing risk factors and antithrombotic agents.
- Growing interest in natural food products and bioactive compounds for cardiovascular disorder prevention and treatment.
Purpose of the Study:
- To review the antiplatelet properties of natural products and food-derived bioactive constituents.
- To explore the mechanisms underlying these antiplatelet activities in the context of atherothrombosis.
Main Methods:
- Literature review of the atherothrombotic process.
- Up-to-date review of antiplatelet properties of specific natural products and food constituents.
- Discussion of underlying antiplatelet mechanisms.
Main Results:
- Healthy diets, such as the Mediterranean diet, offer cardioprotective effects in CVD prevention.
- Beneficial effects are linked to improved lipid profiles, vascular function, and reduced oxidative stress and inflammation.
- Natural dietary compounds, including ω-3 PUFA, olive oil, garlic, onions, tomatoes, mushrooms, polyphenol-rich beverages, and cocoa, exhibit antiplatelet activities.
Conclusions:
- Natural food products and their bioactive components play a role in preventing and treating cardiovascular disorders.
- Dietary interventions, particularly those rich in functional foods, can modulate key pathways in atherosclerosis.
- The antiplatelet effects of these natural compounds contribute to reducing thrombotic risk in cardiovascular disease.
Abstract:
Cardiovascular diseases (CVD) and its main underlying cause, atherothrombosis, are the major culprits of morbidity and mortality worldwide. Apart from the treatment of cardiovascular risk factors and the use of antithrombotic agents there is considerable interest in the role of natural food products and their bioactive components in the prevention and treatment of cardiovascular disorders. The consumption of healthy diets rich in functional foods, such as the Mediterranean diet, has shown to exert profound cardioprotective effects in the primary and secondary prevention of CVD. Moreover, accumulating data have attributed these beneficial effects, at least in part, to the modulation of key players in the pathogenesis of atherosclerosis, including amelioration in the lipid profile and vascular function and a decrease in oxidative stress and inflammation. Although with a much less clear picture, natural dietary compounds have also demonstrated to exert antiplatelet activities, further contributing to reduce the thrombotic risk. This article provides a brief overview of the atherothrombotic process to further provide an up-to-date review of the antiplatelet properties exerted by natural products and/or food-derived bioactive constituents - including ω-3 PUFA, olive oil, garlic and onions, tomatoes, mushrooms, polyphenol-rich beverages, and flavonol-rich cocoa - as well as to describe the mechanisms underlying these antiplatelet activities.
More Related Videos
09:13Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
Published on: April 6, 2017
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Clot Retraction and Fibrinolysis